Literature DB >> 27009033

Clinical Practice Guidelines From the Cystic Fibrosis Foundation for Preschoolers With Cystic Fibrosis.

Thomas Lahiri1, Sarah E Hempstead2, Cynthia Brady3, Carolyn L Cannon4, Kelli Clark5, Michelle E Condren6, Margaret F Guill7, R Paul Guillerman8, Christina G Leone9, Karen Maguiness10, Lisa Monchil11, Scott W Powers12, Margaret Rosenfeld13, Sarah Jane Schwarzenberg14, Connie L Tompkins15, Edith T Zemanick16, Stephanie D Davis10.   

Abstract

Cystic fibrosis (CF) clinical care guidelines exist for the care of infants up to age 2 years and for individuals ≥6 years of age. An important gap exists for preschool children between the ages of 2 and 5 years. This period marks a time of growth and development that is critical to achieve optimal nutritional status and maintain lung health. Given that disease often progresses in a clinically silent manner, objective and sensitive tools that detect and track early disease are important in this age group. Several challenges exist that may impede the delivery of care for these children, including adherence to therapies. A multidisciplinary committee was convened by the CF Foundation to develop comprehensive evidence-based and consensus recommendations for the care of preschool children, ages 2 to 5 years, with CF. This document includes recommendations in the following areas: routine surveillance for pulmonary disease, therapeutics, and nutritional and gastrointestinal care.
Copyright © 2016 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2016        PMID: 27009033     DOI: 10.1542/peds.2015-1784

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  40 in total

1.  Macronutrient intake in preschoolers with cystic fibrosis and the relationship between macronutrients and growth.

Authors:  Stephanie S Filigno; Shannon M Robson; Rhonda D Szczesniak; Leigh A Chamberlin; Meredith A Baker; Stephanie M Sullivan; John Kroner; Scott W Powers
Journal:  J Cyst Fibros       Date:  2017-02-06       Impact factor: 5.482

Review 2.  Carbapenem-Resistant Gram-Negative Bacterial Infections in Children.

Authors:  David Aguilera-Alonso; Luis Escosa-García; Jesús Saavedra-Lozano; Emilia Cercenado; Fernando Baquero-Artigao
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

3.  Abnormal Lung Clearance Index in Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID) Children with Otherwise Normal FEV1.

Authors:  Ajay S Kasi; Choo Phei Wee; Thomas G Keens; Danieli B Salinas
Journal:  Lung       Date:  2019-12-16       Impact factor: 2.584

4.  Risk stratification model to detect early pulmonary disease in infants with cystic fibrosis diagnosed by newborn screening.

Authors:  Lacrecia J Britton; Gabriela R Oates; Robert A Oster; Staci T Self; Robert B Troxler; Wynton C Hoover; Hector H Gutierrez; William T Harris
Journal:  Pediatr Pulmonol       Date:  2016-08-24

5.  Tobacco smoke exposure in pediatric cystic fibrosis: A qualitative study of clinician and caregiver perspectives on smoking cessation.

Authors:  Gabriela R Oates; William T Harris; Hector H Gutierrez; Cathy Mims; Sarah B Rutland; Corilyn Ott; Soumya J Niranjan; Isabel C Scarinci; Susan C Walley
Journal:  Pediatr Pulmonol       Date:  2020-06-08

6.  22q and two: 22q11.2 deletion syndrome and coexisting conditions.

Authors:  Jennifer L Cohen; Terrence B Crowley; Daniel E McGinn; Carey McDougall; Marta Unolt; Michele P Lambert; Beverly S Emanuel; Elaine H Zackai; Donna M McDonald-McGinn
Journal:  Am J Med Genet A       Date:  2018-09-23       Impact factor: 2.802

7.  Early acquisition and conversion of Pseudomonas aeruginosa in Hispanic youth with cystic fibrosis in the United States.

Authors:  Meghan E McGarry; Chiung-Yu Huang; Dennis W Nielson; Ngoc P Ly
Journal:  J Cyst Fibros       Date:  2020-11-05       Impact factor: 5.482

Review 8.  Novel imaging techniques for cystic fibrosis lung disease.

Authors:  Jennifer L Goralski; Neil J Stewart; Jason C Woods
Journal:  Pediatr Pulmonol       Date:  2021-02

Review 9.  Cystic Fibrosis.

Authors:  Kimberly M Dickinson; Joseph M Collaco
Journal:  Pediatr Rev       Date:  2021-02

10.  Neutrophil Extracellular Traps Increase Airway Mucus Viscoelasticity and Slow Mucus Particle Transit.

Authors:  Rosalie S Linssen; Guihong Chai; Jonathan Ma; Apparao B Kummarapurugu; Job B M van Woensel; Reinout A Bem; Logan Kaler; Gregg A Duncan; Lei Zhou; Bruce K Rubin; Qingguo Xu
Journal:  Am J Respir Cell Mol Biol       Date:  2021-01       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.